Brief: Guerbet Announces FDA Approval Of Elucirem™ (Gadopiclenol)

Guerbet SA

21/09/2022 18:07

Sept 21 (Reuters) - Guerbet SA  GRBT.PA :
    * GUERBET ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA)
APPROVAL OF ELUCIREM™ (GADOPICLENOL)
    * ELUCIREMTM (GADOPICLENOL) WILL BE PRODUCED IN UNITED
STATES AND
FRANCE
    * ELUCIREMTM WILL BE MARKETED BY GUERBET IN UNITED STATES IN
BOTTLE AND PRE-FILLED SYRINGE FORM
    * FDA IS FIRST HEALTH AUTHORITY TO HAVE APPROVED ELUCIREMTM
    * IT IS CURRENTLY IN PROCESS OF EXAMINATION BY EUROPEAN
MEDICINES
AGENCY VIA A CENTRALIZED PROCEDURE

Source text for Eikon:  ID:nGNEKcKsN 
Further company coverage:  GRBT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))